Beijing: China has approved the registration applications of two domestically developed Covid-19 vaccines with conditions, the National Medical Products Administration said.
An inactivated vaccine from the Wuhan Institute of Biological Products, an affiliate of China National Biotec Group of Sinopharm, was allowed to enter the market on a conditional basis, the administration said on Thursday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
